Liquid Biopsy in Lung Cancer
NCT03479099 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111
Last updated 2019-08-28
Summary
The purpose of this study is to assess clinical utility of combined circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) in the diagnosis of primary lung cancer.
Conditions
- Lung Cancer (Diagnosis)
- Circulating Tumor Cell
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-12
- Primary Completion
- 2019-03-11
- Completion
- 2019-03-11
Countries
- South Korea
Study Locations
More Related Trials
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
NCT03376971 ·Status: COMPLETED ·Phase: NA
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapy
NCT04704960 ·Status: UNKNOWN
-
A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females
NCT06181929 ·Status: RECRUITING ·Phase: NA
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02412384 ·Status: COMPLETED
-
NSCLC Liquid Biopsies and Exhaled VOC
NCT06707519 ·Status: RECRUITING
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT06105177 ·Status: RECRUITING
-
Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer
NCT06301295 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors
NCT05921474 ·Status: UNKNOWN
-
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
NCT01482585 ·Status: UNKNOWN
-
Analysis of Screen-detected Lung Cancers' Genomic Traits
NCT04204499 ·Status: ACTIVE_NOT_RECRUITING